MASON STREET ADVISORS, LLC - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MASON STREET ADVISORS, LLC ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$148,000
+5.7%
13,219
+3.6%
0.00%0.0%
Q2 2017$140,000
+18.6%
12,757
+6.0%
0.00%
+33.3%
Q1 2017$118,000
-1.7%
12,037
+7.9%
0.00%0.0%
Q4 2016$120,000
+14.3%
11,156
+8.5%
0.00%0.0%
Q3 2016$105,000
-17.3%
10,281
+5.4%
0.00%
-25.0%
Q2 2016$127,0009,7570.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Athos Capital Ltd 410,389$4,596,0003.46%
GLG Partners LP 2,586,437$28,968,0001.54%
Nine Chapters Capital Management LLC 32,300$362,0000.80%
FNY Partners Fund LP 335,900$3,762,0000.64%
MENTA CAPITAL LLC 373,523$4,183,0000.61%
Yakira Capital Management, Inc. 85,500$958,0000.32%
Sapphire Star Partners LP 18,724$209,0000.27%
GAM Holding AG 541,025$6,059,0000.26%
Bowling Portfolio Management LLC 127,873$1,432,0000.22%
Kassirer Asset Management Corp 15,000$168,0000.16%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders